Table 1.
Serum Lipase, CEA, Alkaline Phosphatase levels linked to clinical events.
| Date | Event | Lipase (u/L) | CEA (ng/ml) | Alpha fetoprotein ng/ml | Alk. Phos. (IU/L) |
|---|---|---|---|---|---|
| Oct/2003 | Prior to pancreatectomy | 100 | N/A | N/A | 121 |
| Oct/2003 | Post pancreatectomy and RFA | 32 | N/A | 6.4 | 129 |
| April 2004 | Post Chemoradiation/Two new liver mets. | 0.6 | 14.2 | 101 | |
| April 2004 | Post radioablation of liver mets. | 13 | 0.5 | 8.7 | 121 |
| August 2004 | Post paclitaxel/thalidomide | 12 | 0.5 | 7.0 | 116 |
| Feb/2005 | Two new liver mets/Capecitabine initiated | 1.2 | 8.2 | 130 | |
| August/2005 | Capecitabine treatment discontinued with worsening disease | 7.8 | 240 | ||
| 2006 | Before doxorubicin | 2027 | 1.5 | 374 | |
| 2006 | During doxorubicin | 90 | 3.2 | 5.8 | 190 |
| 2007 | Before intra-arterial brachytherapy with Sirspheres | 100 | 3.4 | 6.3 | 179 |
| 2007 | After intra-arterial brachytherapy with Sirspheres | 31 | 3.5 | 14.1 | 457 |
| Jan 2008 | Before radiofrequency ablation | 75 | 3.4 | 13.2 | 382 |
| Jan 2008 | After radiofrequency ablation/before cryotherapy | 110 | 3.3 | 9.5 | 368 |
| July 2008 | progression of liver lesions and development of mesenteric lesions | 150 | 3.4 | 8.9 | 431 |
| Nov 2008 | Before external beam radiation to a progressive liver lesion | 222 | 4.1 | 9.8 | 583 |
| January 2009 | hepatic and mesenteric disease had worsened | 682 | 7.4 | 609 |